This same early onset of cognitive deficits is also seen in two other mouse models of AD, tTa:APPsi mice, in which amyloid precursor protein (APP) expression is driven by the tetracycline transactivator (Melnikova et al., 2016) and APP(SW) mice which overexpress human APP (King et al., 1999). Here, APP is linked to Alzheimer disease.